StockMacro
Menu

Anthony Mancini

Insider (Form 4 reporting owner): See Remarks CIK 2124509Name as filed: Mancini AnthonyIts filings on EDGARAll insiders

Measures activity, not value. Not investment advice.

Since 25 Mar 2026, sold $10.4M in 10 sales (9 under a 10b5-1 plan set in advance) of Revolution Medicines.

Companies

Role on the latest Form 4 for each; open-market trades counted
CompanyRoleTrades fromtoPurchasesSales
Revolution Medicines RVMDSee Remarks25 Mar 20269 Nov 2026–10$10.4M

What the share price did after their trades Share price return after each open-market trade, from the first close after the Form 4 became public, minus the return of the company's sector fund (the S&P 500 fund when the sector has none) over the same days. Median over the trades, in percentage points; at most one trade per company, side and month. It describes the past.

Median return minus the sector fund, in percentage points; "too few trades" under 5
Open-market tradesAfter 3 monthsAfter 6 monthsAfter 12 months
After salestoo few trades4 tradestoo few trades2 tradesno trade old enough

For a sale, a negative number means the shares did worse than the sector afterwards. It describes the past, not what comes next.

By year

Counted open-market trades, by trade date
YearPurchasesBoughtSalesSoldNet
2026––10$10.4M-$10.4M

Every trade

10, newest first; open-market purchases and sales only
Trade dateCompanySideSharesPriceValuePlanned Rule 10b5-1 plan: the insider set the trade up in advance, so its timing says less about their view. The box exists on Form 4 since April 2023. Filing
9 Nov 2026Revolution Medicines RVMDSellafter exercising options811$200.00$162K10b5-1 planForm 4filed 12 Nov 2026
26 Oct 2026Revolution Medicines RVMDSellafter exercising options2,310$186.99$432K10b5-1 planForm 4filed 28 Oct 2026
24 Sep 2026Revolution Medicines RVMDSellafter exercising options3,708$200.45$743K10b5-1 planForm 4filed 28 Sep 2026
18 Sep 2026Revolution Medicines RVMDSell1,764$196.94$347K10b5-1 planForm 4filed 22 Sep 2026
16 Sep 2026Revolution Medicines RVMDSell1,774$199.24$353K10b5-1 planForm 4filed 18 Sep 2026
10 Sep 2026Revolution Medicines RVMDSellafter exercising options15,448$204.16$3.2M10b5-1 planForm 4filed 14 Sep 2026
16 Jun 2026Revolution Medicines RVMDSell4,615$156.12$720KNoForm 4filed 18 Jun 2026
26 May 2026Revolution Medicines RVMDSellafter exercising options3,121$153.99$481K10b5-1 planForm 4filed 28 May 2026
27 Apr 2026Revolution Medicines RVMDSellafter exercising options3,120$132.41$413K10b5-1 planForm 4filed 29 Apr 2026
25 Mar 2026Revolution Medicines RVMDSellafter exercising options37,450$95.57$3.6M10b5-1 planForm 4filed 26 Mar 2026

From Form 4: open-market purchases (code P) and sales (code S) only; awards, option exercises, tax withholding and gifts are not counted. Greyed rows are amended copies or another filer's report of the same trade and count nowhere. Measures activity, not value. Not investment advice.